CSL CSL Ltd
- 300.485
- -0.285-0.09%
CSL Ltd News
The CSL Limited (ASX:CSL) Yearly Results Are Out And Analysts Have Published New Forecasts
Top Brokers Name 3 ASX Shares to Buy Today 14 August 2024
CSL Target Price Raised 8% to A$329.62/Share by Jarden>CSL.AU
Correct: CSL Price Target Cut 2% to A$291.78/Share by Wilsons
CSL Ltd To Go Ex-Dividend On September 9th, 2024 With 2.20298 AUD Dividend Per Share
Earnings Call Summary | CSL LTD SPON ADR EACH REPR 0.5 ORD(CSLLY.US) Q4 2024 Earnings Conference
CSL Posts Strong Profit but Investors Unimpressed
Australian Shares Rise Amid Easing Market Volatility, Partly Offset by RBA's Recent Hawkish Stance
Why Are ASX Healthcare Shares Dragging on the ASX 200 Today?
Why CSL, James Hardie, Netwealth, and Seek Shares Are Dropping Today
Everything You Need to Know About the Record CSL Dividend
CSL Reports 25% Profit Increase as Immunoglobulins and Plasma Collections Lead Growth
CSL Profit Outlook Looks Weaker Than Expected -- Market Talk
CSL Share Price Tumbles After FY25 Guidance Disappoints
CSL Annual Profit Rises by 20% on Immunoglobulins Growth -- Update
CSL Shares on Watch Amid US$3b FY 2024 Profit
CSL Posts 11% Increase in Fiscal 2024 Revenue; EPS Up
CSL: Has a Number of Efficiency Initiatives Underway in Plasma Collections, Manufacturing Operations
CSL: Vifor Continues to Grow Iron Volume in Europe Despite Generic Entrants
CSL: Outlook for Behring Positive But Competitive Pressures Increased Recently
Analysis
Price Target
No Data
